Stay updated on Cabotegravir vs TDF/FTC in Women Clinical Trial

Sign up to get notified when there's something new on the Cabotegravir vs TDF/FTC in Women Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabotegravir vs TDF/FTC in Women Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now shown on the site, and the prior notice about government funding lapse as well as the previous Revision: v3.4.1 entry have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T10:56:11.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding that may affect data updates and updated the page version from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T06:25:29.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Show glossary option added and footer/metadata labels updated (Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, Revision: v3.4.0) replacing older labels (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4). No changes to the core study content or user-facing study details; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T04:27:16.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:50:54.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Added a consolidated Locations section listing study sites (South-East District, Nyanza, Central Region, Gauteng, KwaZulu-Natal, Western Cape, Mashonaland East Province) and updated the revision tag to v3.3.3; removed the previous 'X Locations' subheadings (e.g., 'South-East District Locations', 'Nyanza Locations').
    Difference
    0.7%
    Check dated 2025-12-23T09:42:58.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    Publication notes updated to indicate PubMed-sourced publications are automatically filled and the page revision was updated to v3.3.2; the older version note referencing v3.2.0 was removed.
    Difference
    0.1%
    Check dated 2025-11-24T18:48:43.000Z thumbnail image

Stay in the know with updates to Cabotegravir vs TDF/FTC in Women Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabotegravir vs TDF/FTC in Women Clinical Trial page.